111 related articles for article (PubMed ID: 7972246)
1. Relationship of peroxisome proliferator-induced cellular effects to hepatocarcinogenesis.
Popp JA; Cattley RC; Miller RT; Marsman DS
Prog Clin Biol Res; 1994; 387():193-207. PubMed ID: 7972246
[No Abstract] [Full Text] [Related]
2. [Proliferation of peroxisomes and the hepatocarcinogenic process].
Palut D
Rocz Panstw Zakl Hig; 1997; 48(1):1-11. PubMed ID: 9273657
[TBL] [Abstract][Full Text] [Related]
3. Stereoselective effects of chiral clofibric acid analogs on rat peroxisome proliferator-activated receptor alpha (rPPAR alpha) activation and peroxisomal fatty acid beta-oxidation.
Rangwala SM; O'Brien ML; Tortorella V; Longo A; Loiodice F; Noonan DJ; Feller DR
Chirality; 1997; 9(1):37-47. PubMed ID: 9094202
[TBL] [Abstract][Full Text] [Related]
4. Delineating peroxisome proliferator action to improve human risk assessment.
Green S; Issemann I; Tugwood JD; Prince RA; Aldridge TC
Prog Clin Biol Res; 1994; 387():311-33. PubMed ID: 7972256
[No Abstract] [Full Text] [Related]
5. Diminished hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome proliferator-activated receptor alpha.
Cheung C; Akiyama TE; Ward JM; Nicol CJ; Feigenbaum L; Vinson C; Gonzalez FJ
Cancer Res; 2004 Jun; 64(11):3849-54. PubMed ID: 15172993
[TBL] [Abstract][Full Text] [Related]
6. Perplexing peroxisome proliferators.
Citron M
Environ Health Perspect; 1995 Mar; 103(3):232-5. PubMed ID: 7768221
[No Abstract] [Full Text] [Related]
7. Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis.
Ashby J; Brady A; Elcombe CR; Elliott BM; Ishmael J; Odum J; Tugwood JD; Kettle S; Purchase IF
Hum Exp Toxicol; 1994 Nov; 13 Suppl 2():S1-117. PubMed ID: 7857698
[TBL] [Abstract][Full Text] [Related]
8. Hepatocarcinogenesis of peroxisome proliferators.
Rao MS; Reddy JK
Ann N Y Acad Sci; 1996 Dec; 804():573-87. PubMed ID: 8993574
[No Abstract] [Full Text] [Related]
9. The relevance of peroxisome proliferation and cell proliferation in peroxisome proliferator-induced hepatocarcinogenesis.
Rao MS; Reddy JK
Drug Metab Rev; 1989; 21(1):103-10. PubMed ID: 2696631
[No Abstract] [Full Text] [Related]
10. Peroxisome proliferator-activated receptor alpha required for gene induction by dehydroepiandrosterone-3 beta-sulfate.
Peters JM; Zhou YC; Ram PA; Lee SS; Gonzalez FJ; Waxman DJ
Mol Pharmacol; 1996 Jul; 50(1):67-74. PubMed ID: 8700121
[TBL] [Abstract][Full Text] [Related]
11. The role of peroxisome proliferator activated receptor alpha in peroxisome proliferation, physiological homeostasis, and chemical carcinogenesis.
Gonzalez FJ
Adv Exp Med Biol; 1997; 422():109-25. PubMed ID: 9361819
[No Abstract] [Full Text] [Related]
12. Rat 17 beta-hydroxysteroid dehydrogenase type IV is a novel peroxisome proliferator-inducible gene.
Corton JC; Bocos C; Moreno ES; Merritt A; Marsman DS; Sausen PJ; Cattley RC; Gustafsson JA
Mol Pharmacol; 1996 Nov; 50(5):1157-66. PubMed ID: 8913347
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-induced pleiotropic responses: pursuit of a phenomenon.
Reddy JK; Chu R
Ann N Y Acad Sci; 1996 Dec; 804():176-201. PubMed ID: 8993544
[No Abstract] [Full Text] [Related]
14. Mechanism-based risk assessment of peroxisome proliferating rodent hepatocarcinogens.
Williams GM; Perrone C
Ann N Y Acad Sci; 1996 Dec; 804():554-72. PubMed ID: 8993573
[No Abstract] [Full Text] [Related]
15. Differentiation of rat oval cells after activation of peroxisome proliferator-activated receptor alpha43.
Kaplanski C; Pauley CJ; Griffiths TG; Kawabata TT; Ledwith BJ
Cancer Res; 2000 Feb; 60(3):580-7. PubMed ID: 10676640
[TBL] [Abstract][Full Text] [Related]
16. The relevance of hepatic peroxisome proliferation in rats to assessment of human carcinogenic risk for pharmaceuticals.
Kluwe WM
Regul Toxicol Pharmacol; 1994 Oct; 20(2):170-86. PubMed ID: 7846304
[TBL] [Abstract][Full Text] [Related]
17. A knockout for risk assessment.
Bell DR
Hum Exp Toxicol; 1995 Oct; 14(10):850-1. PubMed ID: 8562126
[No Abstract] [Full Text] [Related]
18. [Peroxisome proliferators and hepatocarcinogenesis].
Tamura H
Seikagaku; 1995 Aug; 67(8):1044-7. PubMed ID: 7594872
[No Abstract] [Full Text] [Related]
19. Role of peroxisome proliferator-activated receptor-alpha (PPARalpha) in bezafibrate-induced hepatocarcinogenesis and cholestasis.
Hays T; Rusyn I; Burns AM; Kennett MJ; Ward JM; Gonzalez FJ; Peters JM
Carcinogenesis; 2005 Jan; 26(1):219-27. PubMed ID: 15447978
[TBL] [Abstract][Full Text] [Related]
20. Oxidative DNA damage caused by persistent peroxisome proliferation: its role in hepatocarcinogenesis.
Reddy JK; Rao MS
Mutat Res; 1989 Sep; 214(1):63-8. PubMed ID: 2671702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
